Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Long-term Investment Intensity

Latest as of September 2019: 1.4%

Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Long-term Investment Intensity of 1.4% as of September 2019. Long-term investments of CN¥146.88 Million represent 1.4% of total assets of CN¥10.26 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Guizhou Xinbang Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

LT Investment Intensity

1.4%
LT Investments / Total Assets

Long-term Investments

CN¥146.88 Million
CNY

Total Assets

CN¥10.26 Billion
CNY

Country

China
SHE

Guizhou Xinbang Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Guizhou Xinbang Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 1.4%, reflecting long-term investments of CN¥146.88 Million against total assets of CN¥10.26 Billion CNY. See 002390 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Long-term Investment Intensity for Guizhou Xinbang Pharmaceutical Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Guizhou Xinbang Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002390 total asset value.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 0.8% CN¥88.45 Million CN¥10.85 Billion ▲ +0.0 pp
2017 0.8% CN¥92.93 Million CN¥11.95 Billion ▲ +0.5 pp
2016 0.3% CN¥30.05 Million CN¥10.80 Billion ▼ -0.7 pp
2015 1.0% CN¥66.05 Million CN¥6.50 Billion —
pp = percentage points